In the last trading session, 1.16 million Tff Pharmaceuticals Inc (NASDAQ:TFFP) shares changed hands as the company’s beta touched 1.10. With the company’s per share price at $0.28 changed hands at $0.05 or 23.81% during last session, the market valuation stood at $16.85M. TFFP’s last price was a discount, traded about -432.14% off its 52-week high of $1.49. The share price had its 52-week low at $0.21, which suggests the last value was 25.0% up since then. When we look at Tff Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.35 million shares, with the 3-month average coming to 124.18K.
Analysts gave the Tff Pharmaceuticals Inc (TFFP) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TFFP as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Tff Pharmaceuticals Inc’s EPS for the current quarter is expected to be -$0.09.
Tff Pharmaceuticals Inc (NASDAQ:TFFP) trade information
Instantly TFFP was in green as seen at the end of in last trading. With action 25.99%, the performance over the past five days has been green. The jump to weekly highs of 0.3498 on Friday, 11/17/23 added 23.81% to the stock’s daily price. The company’s shares are showing year-to-date downside of -72.86%, with the 5-day performance at 25.99% in the green. However, in the 30-day time frame, Tff Pharmaceuticals Inc (NASDAQ:TFFP) is -13.51% down. Looking at the short shares, we see there were 15470.0 shares sold at short interest cover period of 0.18 days.
The consensus price target for the stock as assigned by Wall Street analysts is $8.00, meaning bulls need an upside of 96.5% from its current market value. According to analyst projections, TFFP’s forecast low is $7.00 with $9.00 as the target high. To hit the forecast high, the stock’s price needs a -3114.29% plunge from its current level, while the stock would need to soar -2400.0% for it to hit the projected low.
Tff Pharmaceuticals Inc (TFFP) estimates and forecasts
Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Tff Pharmaceuticals Inc will rise 10.00%, while the growth in revenue is estimated to hit 52.60% for the next quarter. Year-over-year growth is forecast to reach 21.00% up from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of $100k. 2 analysts are of the opinion that Tff Pharmaceuticals Inc’s revenue for the quarter ending Mar 2024 will be $100k. The company’s revenue for the corresponding quarters a year ago was $313k and $51k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -68.10%. The estimates for the next quarter sales put growth at 96.10%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -155.67%. The 2023 estimates are for Tff Pharmaceuticals Inc earnings to increase by 52.83%.
Tff Pharmaceuticals Inc is expected to release its next quarterly earnings report on November 14.
Tff Pharmaceuticals Inc (NASDAQ:TFFP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.01% of Tff Pharmaceuticals Inc shares while 18.18% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 20.42%. There are 18.18% institutions holding the Tff Pharmaceuticals Inc stock share, with AIGH Capital Management LLC the top institutional holder. As of Jun 29, 2023, the company held 2.63% of the shares, roughly 1.56 million TFFP shares worth $0.73 million.
Carlson Capital. L.P. holds the second largest percentage of outstanding shares, with 2.16% or 1.28 million shares worth $0.6 million as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 0.56 million shares estimated at $0.26 million under it, the former controlled 0.95% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.45% of the shares, roughly 0.27 million shares worth around $0.13 million.